Spatial localization and functional role of IL-13Rα1 signalling in atopic dermatitis
Zachary A. Bordeaux, Ahmed Rajeh, Jackson Adams, Ferda Cevikbas, Shawn G. Kwatra, Madan M. Kwatra, Ph.D,
Publications
EBLASAKIMAB
Insight Into Novel Itch Pathways and Spontaneous Neuronal Activity by Targeting Interleukin 13 Receptor Alpha 1 (IL13Rα1) With Eblasakimab
Yannick Miron, Paul Miller, Carl Firth and Ferda Cevikbas
EBLASAKIMAB
Eblasakimab improves itch and sleep loss in adult patients with moderate-to-severe atopic dermatitis in a randomized, double-blinded, placebo-controlled, Phase 1 study
Karen A. Veverka, Josemund Menezes, Steven Tien Guan Thng, Eric Simpson
EBLASAKIMAB
Eblasakimab improves multiple disease measures in adult patients with moderate-to-severe atopic dermatitis in a randomized, double-blinded, placebo-controlled, Phase 1 study
Karen A. Veverka, Josemund Menezes, Steven Tien Guan Thng, Melinda Gooderham, Eric Simpson
EBLASAKIMAB
Eblasakimab improves multiple disease measures in adult patients with moderate-to-severe atopic dermatitis in a randomized, double-blinded, placebo-controlled, Phase 1 study
Ferda Cevikbas, Jacob P. Thyssen, Eric Simpson, Alison Ward, Steven Tien Guan Thng, Karen A. Veverka
FARUDODSTAT
Investigating dihydroorotate dehydrogenase inhibitor mediated mitochondrial dysfunction in hepatic in vitro models
S.W. Jones, S.L Penman, N.S French, B.K Park, A.E Chadwick.
Toxicology in Vitro (2021), 72, 105096 – 105096